LeMaitre Vascular (NASDAQ:LMAT) was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating in a research note issued on Wednesday.
A number of other brokerages have also commented on LMAT. Benchmark lowered LeMaitre Vascular from a “buy” rating to a “hold” rating in a research report on Friday, October 27th. First Analysis lowered LeMaitre Vascular from an “overweight” rating to an “equal weight” rating and set a $34.00 target price on the stock. in a research report on Friday, October 27th. Zacks Investment Research lowered LeMaitre Vascular from a “buy” rating to a “hold” rating in a research report on Friday, November 10th. Stifel Nicolaus reiterated a “buy” rating on shares of LeMaitre Vascular in a research report on Sunday, October 29th. Finally, Canaccord Genuity decreased their price target on LeMaitre Vascular from $30.00 to $29.00 and set a “hold” rating for the company in a report on Friday, October 27th. Six research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. LeMaitre Vascular currently has an average rating of “Hold” and an average price target of $32.20.
Shares of LeMaitre Vascular (NASDAQ:LMAT) opened at $34.38 on Wednesday. The company has a market capitalization of $654.82, a P/E ratio of 44.65, a P/E/G ratio of 2.61 and a beta of 0.53. LeMaitre Vascular has a 52-week low of $19.82 and a 52-week high of $39.88.
COPYRIGHT VIOLATION NOTICE: “LeMaitre Vascular (LMAT) Stock Rating Upgraded by BidaskClub” was published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be read at https://www.com-unik.info/2018/02/07/lemaitre-vascular-lmat-stock-rating-upgraded-by-bidaskclub.html.
About LeMaitre Vascular
LeMaitre Vascular, Inc is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment.
Receive News & Ratings for LeMaitre Vascular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular and related companies with MarketBeat.com's FREE daily email newsletter.